1. SLC25A1 and ACLY maintain cytosolic acetyl-CoA to regulate ferroptosis susceptibility via FSP1 acetylation.EMBO Journal. Li, W.#, Han, J.#, Huang, B. #, Xu, T. #, Wan, Y., Luo, D., Kong, W., Yu, Y., Zhang, L., Nian, Y. *, Chu, B. *,Yin, C.*2025, https://doi.org/10.1038/s44318-025-00369-5

2. PTPN23-dependent activation of PI3KC2α is a therapeutic vulnerability of BRAF-mutant cancers.Journal of Experimental Medicine. 222(3): e20241147. He, Y.#, Li, W.#, Zhang, M. #, Wang, H., Lin, P., Yu, Y., Huang, B., Hao, M., He, J., Kong, W., Luo, D., Xu, T., Wang, J., Huang, Y., Zhao, Q., Liu, Y., Zhang, J., Nian, Y., Zhang, L., Zhu, B.,Yin, C.*2025/01. DOI:10.1084/jem.20241147

3. Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis.Nature Communications. 16: 867. Huang, B.#, Wang, H.#, Liu, S.#, Hao, M.#, Luo, D., Zhou, Y., Huang, Y., Nian, Y., Zhang, L., Chu, B.,Yin, C.*2025/01. DOI:10.1038/s41467-025-56344-5

4. Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma.Nature Communications. 15, 10088. Wen, Y.#, Wang, H.#, Yang, X.#, Zhu, Y., Li, M., Ma, X., Huang, L., Wan, R., Zhang, C., Li, S., Jia, H., Guo, Q., Lu, X., Li, Z., Shen, X., Zhang, Q.*, Si, L.*,Yin, C.*, Liu, T*. 2024/11.

5. Gut microbial metabolism in ferroptosis and colorectal cancer.Trends in Cell Biology. 10(11), Cui, W.#, Hao, M.#, Yang, X.*,Yin, C.*, Chu, B*. 2024/08.

6. Tryptophan metabolism acts as a new anti-ferroptotic pathway to mediate tumor growth.Advanced Science. 10(6), 2204006. Liu, D.#, Liang, C.#, Huang, B.#, Zhuang, X., Cui, W., Yang, L., Yang, Y., Zhang, Y., Fu, X., Zhang, X., Du, L., Gu, W., Wang, X.,Yin, C.*, Chai, R.*, Chu, B.* 2023/02.

7. Aberrant promoter methylation of Wnt inhibitory factor-1 gene is a potential target for treating psoriasis.Clinical Immunology. 252023, 0, 109294. Liu, L.#, Zhou, Y.#, Luo, D.#, Sun, X., Li, H., Lu, Y., Wang, J., Zhang, M., Lin, N.,Yin, C.*, Li, X.*, 2023/01.

8.AMPK phosphorylates ZDHHC13 to increase MC1R activity and suppress melanomagenesis.Cancer Research. 83 (7): 1062–1073.Sun, Y.#, Li, X.#,Yin, C.#, Zhang, J., Liang, E., Wu, X., Ni, Y., Arbesman, J., Goding, C. R.,Chen, S. 2023/01

9. Pharmacological targeting of STK19 inhibits oncogenic NRAS-driven melanomagenesis.Cell. 176(5), 1113-1127.Yin, C.#, Zhu, B.#, Zhang, T.#, Liu, T.#, Chen, S., Liu, Y., Li, X., Miao, X., Li, S., Mi, X., Zhang, J., Li, L., Wei, G., Xu, Z., Gao, X., Huang, C., Wei, Z., Goding, C. R., Wang, P.*, Deng, X.*, Cui, R.* 2019/02

10. Palmitoylation-dependent activation of MC1R prevents melanomagenesis.Nature. 549(7672), 399-403. Chen, S.#, Zhu, B.#,Yin, C.#, Liu, W., Han, C., Chen, B., Liu, T., Li, X., Chen, X., Li, C., Hu, L., Zhou, J., Xu, Z., Gao, X., Wu, X., Goding, C. R., Cui, R. 2017/09